Close on the heels of announcing the hiring of a Chief Talent Officer, Pfizer this morning named a new head of Global Research and Development to replace John LaMattina who had earlier said he'd be leaving the drug company. It was on LaMattina's watch that Pfizer's next potential breakout blockbuster drug, torcetrapib for cholesterol, failed in a late-stage clinical trial.
This is why CNBC makes money. We ask readers and viewers to come up with branding slogans...for free! I've asked you to help me develop a name for my weekly farm reports, and the response has been fantastic.
You unlock this door with the key of capitalism. Beyond the hustle of the trading floor, is the fourth dimension. It’s a dimension of anonymity - of size - of price. Welcome to the land of the secret trades
Today in Germany, DaimlerChrysler is officially changing its name to Daimler AG. While this is a formality, this change made me realize just how much the German automaker has benefited from selling Chrysler. Yes, I know what you are gonna say: "They paid $38 Billion for Chrysler and sold it for $7 Billion. Where's the benefit?"
Activist investor Ralph Whitworth is stepping up pressure on Sprint Nextel's chief executive, Gary Forsee, and other directors of the wireless carrier, the Wall Street Journal reported on its Web site, citing an interview with Whitworth.
Yahoo, is working with auction leader eBay and its PayPal payments unit to block fake e-mails to users purporting to be from eBay and PayPal, hoping to spur on an industry that has been slow to fight the scourge of so-called phishing attacks.
Bain Capital Partners said it will submit for a national security review its proposed $2.2 billion buyout of networking equipment maker 3Com Corp.
Hershey named a new chief executive and president on Tuesday, tapping chief operating officer David West, as the world's biggest chocolate maker continues to grapple with rising food prices.
There is no team in professional sports that works harder to get season ticket holders than the New Jersey Nets. I’ve been to homes where they’ve catered a party for a high net worth season ticket holder to try to convince his friends to buy seats. And I’ve been to a playoff game where Nets general manager Ed Stefanski gave a speech to wavering season ticket holders at halftime to convince them to commit to another season.
The Dow is sitting at a new high and you could argue that the move in the pharmaceuticals sector today is largely market related with Dow components Merck, Pfizer and Johnson & Johnson all trading up. As I write this the biggest dollar gainer in the group is Eli Lilly. But the largest percentage gainer is Schering-Plough.
McCormick said Monday that Alan Wilson, the spice company's chief operating officer, will take over as chief executive as of Jan. 1, replacing Robert Lawless, who plans to retire as CEO.
EBay said Monday that Niklas Zennstrom, co-founder and chief executive of its Internet telephony unit Skype, has stepped down.
The head of Marsh & Mclennan either needs to pack up shop or split his company up if he wants out of Cramer's Hall of Shame.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
General Electric said that, for the first time, it would earn more this year from its operations outside the United States than from in the U.S., mainly because of strong revenue growth in emerging markets.
“Power Lunch” is in St. Louis to focus on biotechnology, medical research and energy generation – and talk to some major players.
The board of directors of Alcatel-Lucent has given chief executive Patricia Russo one month to produce an emergency restructuring plan, the Financial Times reported on Friday.
Time to reach into The Fast Money mailbag and answer more of your questions. Rod writes, “Is there an ETF or an options strategy I can use to trade the US dollar?
I love these Hollywood showdowns. Media moguls know how to slap each other in the face more publicly than perhaps any other group. Steven Spielberg, Jeffrey Katzenberg, and David Geffen, just gave Viacom's top brass one of those slaps.
Everyone's favorite biotech--investors seem to either love it or hate it--was one of the presenters this morning at the UBS Global Life Sciences Conference in New York City. CEO Dr. Mitchell Gold once again did the honors. Generally speaking, biotech investors focus on milestones or key events in drug development.
Wyeth said it named Chief Operating Officer Bernard Poussot to the position of chief executive officer of the company, effective Jan. 1, 2008.